Skip to main content
. 2018 Feb 19;8:3307. doi: 10.1038/s41598-018-21722-1

Table 3.

Effect of ARG-V on tumor growth and the immune organ, function, kidney index in H22 tumor-bearing mice.

Groups Dosage (mg/kg) Increase of body weight (g) Tumor weight (g) Inhibitory rate (%) Thymus index (mg/g) Spleen index (mg/g)
Normal 5.44 1.43 ± 0.19 3.63 ± 0.30
Model 7.11 1.79 ± 0.35 1.94 ± 0.16 6.89 ± 0.54
Positive 25 4.37 0.50 ± 0.11** 72.06 1.24 ± 0.20** 4.40 ± 0.40**
ARG 40 6.30 1.32 ± 0.34**,## 26.26 1.54 ± 0.26**,# 5.71 ± 0.50 **,##
ARG-V 20 5.59 1.03 ± 0.19**,##,a 42.46 1.75 ± 0.24*,## 4.80 ± 0.42**,#,aa
ARG-V 40 4.94 0.55 ± 0.15**,aa 69.27 1.87 ± 0.21##,aa 4.53 ± 0.57 **,aa
ARG-V 80 5.11 0.66 ± 0.17**,#,aa 63.13 1.77 ± 0.18*,##,a 5.34 ± 0.50**,##

Values are expressed as mean ± SD (n = 8).

**P < 0.01 as compared with the model group.#P < 0.05 as compared with the Positive group.

##P < 0.01 as compared with the Positive group.aP < 0.05 as compared with the ARG group.

aaP < 0.01 as compared with the ARG group.